[49] Mizandari M,Pai M,Xi F,et al.Percutaneous intraductal radiofrequency ablation is a safe treatment for malignant biliary obstruction: feasibility and early results[J].Cardiovasc Intervent Radiol,2013,36(3):814-819. ...
[2]Singal AG, Llovet JM, Yarchoan M, et al. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023 Dec 1;78(6):1922-1965. [3]European Association for the Study ...
which were updated by the National Health Commission in December 2019, additional high-quality evidence has emerged from researchers worldwide regarding the diagnosis, staging, and treatment of liver cancer, that requires the guidelines to be updated again. The new ...
[2]Singal AG, Llovet JM, Yarchoan M, et al. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023 Dec 1;78(6):1922-1965. [3]European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Associ...
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide and is the fastest growing cause of cancer death in the United States (U.S.) In the U.S., current national clinical practice guidelines from the 2023 American Association for the Study of Liver Diseases (...
AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–80. Article PubMed Google Scholar Kim H, Choi D, Gwak GY, Lee JH, Park MK, Lee, HIe, et al. Evaluation of esophageal varices on liver computed tomography: receiver operating characteristic analyses ...
Treatment Guidelines Medication Media Gallery Tables ReferencesRecommended Immunotherapy for Hepatocellular Carcinomas: Navigating the Dynamic Treatment Landscape 0.5 CME Credits Diseases & Conditions Fibrolamellar Hepatocellular Carcinoma Imaging Log in or register for free to unlock more Medscape content Unl...
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment Article 17 March 2023 References Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease–meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73–84 (2016). Th...
Guidelines recommend that patients (pt) receive surveillance imaging every 3 to 6 months for the first 2 years after R or A. RW data on treatment and surveillance patterns after curative intent therapy in the US can provide insights into how novel therapies may be integrated into the treatment...
[5]Zhou J,Sun H,Wang Z,et al.Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma(2019 Edition).Liver Cancer.2020;9(6):682-720.doi:10.1159/000509424 [6]中国医师协会介入医师分会临床诊疗指南专委会.中国...